222 related articles for article (PubMed ID: 10968428)
1. Ganciclovir resistance: a matter of time and titre.
Drew WL
Lancet; 2000 Aug; 356(9230):609-10. PubMed ID: 10968428
[No Abstract] [Full Text] [Related]
2. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
3. [Current status of the management of cytomegalovirus retinitis in patients with AIDS].
López-Cortés LF; Pachón-Díaz J
Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):137-41. PubMed ID: 8695680
[No Abstract] [Full Text] [Related]
4. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
[TBL] [Abstract][Full Text] [Related]
5. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
Chou S; Miner RC; Drew WL
J Infect Dis; 2000 Dec; 182(6):1765-8. PubMed ID: 11069251
[TBL] [Abstract][Full Text] [Related]
6. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
[No Abstract] [Full Text] [Related]
7. Advances in treatment for cytomegalovirus retinitis.
Bowers M
BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
[TBL] [Abstract][Full Text] [Related]
8. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
[TBL] [Abstract][Full Text] [Related]
10. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
Limaye AP; Corey L; Koelle DM; Davis CL; Boeckh M
Lancet; 2000 Aug; 356(9230):645-9. PubMed ID: 10968438
[TBL] [Abstract][Full Text] [Related]
11. Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
Spector SA
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):9-12, 15-22. PubMed ID: 11363539
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of antiviral resistance among the herpesvirus group].
Reina J
Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
[No Abstract] [Full Text] [Related]
13. Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
Seo SK; Regan A; Cihlar T; Lin DC; Boulad F; George D; Prasad VK; Kiehn TE; Polsky B
Clin Infect Dis; 2001 Nov; 33(9):e105-8. PubMed ID: 11577375
[TBL] [Abstract][Full Text] [Related]
14. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
Mylonakis E; Kallas WM; Fishman JA
Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
[TBL] [Abstract][Full Text] [Related]
15. Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively.
Baldanti F; Sarasini A; Silini E; Barbi M; Lazzarin A; Biron KK; Gerna G
Scand J Infect Dis Suppl; 1995; 99():103-4. PubMed ID: 8668930
[TBL] [Abstract][Full Text] [Related]
16. Clinically resistant cytomegalovirus retinitis.
Flores-Aguilar M
Semin Ophthalmol; 1995 Jun; 10(2):142-9. PubMed ID: 10155627
[No Abstract] [Full Text] [Related]
17. Ganciclovir resistance in a heart transplant recipient infected by cytomegalovirus.
Manso JV; Lambert JL; Oña M; de la Iglesia JL; Iglesias J
Int J Cardiol; 1999 Sep; 71(1):97-8. PubMed ID: 10522573
[No Abstract] [Full Text] [Related]
18. Treatment and prophylaxis of cytomegalovirus disease.
Levinson ML; Jacobson PA
Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
[TBL] [Abstract][Full Text] [Related]
19. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
Dunn JP; MacCumber MW; Forman MS; Charache P; Apuzzo L; Jabs DA
Am J Ophthalmol; 1995 May; 119(5):587-96. PubMed ID: 7733184
[TBL] [Abstract][Full Text] [Related]
20. Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS.
Minor JR
Am J Hosp Pharm; 1991 Nov; 48(11):2478-9. PubMed ID: 1660675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
